The chromosomal passenger complex (CPC) is a key regulator of chromosome segregation and cytokinesis, and consists of Aurora B kinase, INCENP, Survivin and Borealin. Aurora B is a member of a family of serine/threonine protein kinases, and Survivin belongs to the inhibitors of apoptosis (IAP) gene family, and is also a member of the CPC family. Aurora B and Survivin have also been reported to be overexpressed in various human cancers; however, as yet no studies have investigated the co-expression of Survivin and Aurora B in colorectal carcinoma. Therefore, in the present study, the correlation between Aurora B and Survivin expression was investigated using immunohistochemistry and the associated pathological features in colorectal carcinoma were analyzed. Our present findings showed that nuclear Aurora B and cytoplasmic Survivin expression are strongly associated with and involved in lymph node metastasis in colorectal cancer. Therefore, we suggest that nuclear Aurora B and cytoplasmic Survivin are useful diagnostic markers and therapeutic targets in colorectal carcinoma.
Introduction
Aurora B is a member of a family of serine/threonine protein kinases and phosphorylates a variety of substrate proteins, including histone H3 at ser10, to regulate numerous aspects of cell division, from chromosome condensation to cytokinesis (1, 2) . It is also a protein of the chromosomal passenger complex (CPC), localized on the centromeres from the prophase through to the metaphase-anaphase transition together with Survivin, inner centromere protein (INCENP) and Borealin to regulate segregation and cytokinesis (1) (2) (3) (4) (5) . Aurora B is overexpressed in a various types of cancer including thyroid, prostate and endometrial carcinomas, and its upregulation is associated with cell proliferation, prognosis, metastasis and chromosomal number instability to produce multinuclearity (2) (3) (4) (5) . Previously, we also found that nuclear Aurora B expression is correlated with cell proliferation, multinuclearity and metastasis in oral cancer (6) . However, the expression of Aurora B in colorectal cancer tissues is undetermined.
Survivin is a 142 amino acid protein containing a baculovirus inhibitor of apoptosis repeat protein domain, and thus is involved in inhibiting apoptosis (7, 8) . Additionally, it appears to function as a subunit of CPC to regulate cell division (1) . Survivin is reported to be overexpressed in a variety of human cancers (7) . At present, however, no studies that have investigated the co-expression of Survivin and Aurora B in colorectal carcinoma are available.
Therefore, the aim of this study was to investigate the correlation between Aurora B and Survivin expression and associated pathological features in colorectal carcinoma.
Materials and methods
Patients. Sixty-five patients who had undergone surgical resection for advanced colorectal carcinoma at Hiroshima Memorial Hospital, Japan, were enrolled in this study. In addition, 20 samples of normal colonic mucosa were examined as controls. Tumors from each patient were formalin-fixed and cut into parallel 4-5 mm sections, and the site of deepest tumor invasion was selected by microscopic examination in combination with hematoxylin and eosin staining. The study was approved by the ethics committee of the Hiroshima Memorial Hospital. Informed consent was obtained from all subjects.
Immunohistochemical staining. Immunohistochemical staining for Aurora B and Survivin was performed with the LSAB system (Dako, Kyoto, Japan). In brief, paraffin blocks were cut into 3-4 µm sections. The sections were deparaffinized in xylene for 2 h, dehydrated with graded ethanol washes (100-70%) and treated with 3% hydrogen peroxide for 30 min. The sections were autoclaved three times in 10 mM citrate buffer (pH 6.0) for 5 min to allow antigen retrieval, and incubated overnight in anti-Aurora B primary monoclonal antibody (Transduction Laboratories, San Diego, CA, USA; 1:50 dilution) and anti-Survivin polyclonal antibody (NB500-201, Novus Biological, Littleton, CO, USA; 1:1000 dilution) at 4˚C. Aurora B and Survivin expression was semi-quantitatively estimated by determining nuclear and cytoplasmic localization. Immunoreactivity was graded according to the percentage of positive tumor cells, as follows: +++, strong (>60% of the tumor cells intensely stained); ++, moderate (20-60% intensely stained); +, mild (<20% intensely or weakly stained); or -, no staining. Survivin-and Aurora B-positive cases were graded ++ or +++, and negative cases were graded -or +.
Statistical analysis. The Statcel software package was used to statistically analyze the correlation between pathological factors, including lymph node metastasis, lymphatic invasion, venous invasion and distant metastasis, and the expression of Aurora B and Survivin in colorectal carcinomas. The χ 2 or Fisher's exact test were used for comparison of data between the groups. P<0.05 was considered to indicate a statistically significant difference.
Results

Aurora B and Survivin expression in normal colonic mucosa and colorectal carcinoma.
We examined the expression of Aurora B and Survivin in 20 normal colonic mucosa and 65 colorectal carcinoma samples by immunohistochemistry. In normal colonic mucosa, cells exhibited extremely weak staining of Aurora B and Survivin ( Fig. 1A -a and c, and Table I ). Nuclear Aurora B and nuclear and/or cytoplasmic Survivin exhibited strong staining in colorectal carcinoma ( Fig. 1A-b and d, and Table I ). All cases showed a low nuclear Aurora B expression, and low nuclear and cytoplasmic Survivin in normal colonic mucosa. Although 38 of 65 cases (58.5%) showed nuclear (Table II) . The correlation between nuclear Aurora B and cytoplasmic Survivin expression and pathological factors in colorectal carcinomas was examined. Notably, positive cytoplasmic Survivin (Table III) . Both nuclear Aurora B and cytoplasmic Survivin cases revealed 76% lymph node metastasis.
Aurora B and Survivin expression and pathological factors in primary colorectal tumors and lymph node metastasis.
The varying expression of Aurora B and Survivin in primary colorectal tumors and lymph node metastasis was examined.
Metastatic cases were found to exhibit a higher frequency of nuclear Aurora B and cytoplasmic Survivin expression, and a lower frequency of nuclear Survivin expression than primary tumor cases ( Fig. 1C-g and h, and Table IV) .
Discussion
In the present study, we examined the expression of Aurora B and Survivin in 20 normal colonic mucosa and 65 colorectal carcinoma samples by immunohistochemistry. The results showed that nuclear Aurora B, and nuclear and cytoplasmic Survivin were highly and frequently expressed in colorectal carcinoma cells. Moreover, the overexpression of nuclear Aurora B and cytoplasmic Survivin was significantly correlated with lymph node metastasis. Aurora B kinase is a chromosomal passenger protein and it is essential for chromosome segregation through the phosphorylation of mitotic histone H3 (1, 2) . The phosphory lation status of histone H3 may be balanced by Aurora B kinase activity and PPI phosphatase activity (9) . Overexpression of Aurora B produces multinuclearity and increases ploidy, which is important during human cancer development (2, 10) . In this study, we examined the expression of Aurora B in colorectal carcinoma. Aurora B expression levels were significantly higher in colorectal carcinoma than in normal colonic mucosa, and a high nuclear Aurora B expression was associated with lymph node metastasis. We previously identified that nuclear Aurora B expression is correlated with cell proliferation, multinuclearity and metastasis in oral cancer (6) . Aurora B expression is also associated with a poor prognosis in prostate (4), endometrial (3) and thyroid carcinoma (5) . Aurora B is also responsible for oncogenic Ras-mediated cell transformation, leading to the accelerated proliferation of tumor cells (11) . These findings of these reports therefore confirm the findings of the present study. The detailed mechanism of metastasis promoted by Aurora B overexpression remains to be elucidated. Therefore, the correlation between Aurora B overexpression and migration or invasion of colorectal carcinoma cells should be investigated.
Survivin is a bifunctional protein that suppresses apoptosis and regulates cell division (12, 13) . Nuclear Survivin is suspected to control cell division, whereas cytoplasmic Survivin is considered to be cytoprotective (14) . Survivin has a nuclear export signal (NES) in the linker region between the BIR domain and the COOH-terminal α helix (14) (15) (16) . Results of certain studies have shown the nuclear translocation and accumulation of cytoplasmic Survivin following treatment with leptomycin B (15, 16) . In our study, cytoplasmic Survivin was associated with lymph node metastasis. Cytoplasmic Survivin is characterized as anti-apoptotic and is associated with microtubules, directly or indirectly interfering with the function of caspases (8) . Our result is also supported by observations that the cytoplasmic expression of Survivin is associated with a poor outcome in breast cancer (17) , lymphoma (18) , liver cancer (19) and gastric carcinoma (20) . In our previous study, the cytoplasmic Survivin overexpression was found to be associated with a poor prognosis in colorectal carcinoma (21) .
Previous studies have shown that Survivin acts as a subunit of the chromosomal passenger complex (CPC) and interacts with other subunits of the CPC such as Aurora B, INCENP and Borealin to regulate cell division (12, 13) . We have found that the nuclear Survivin expression is significantly correlated with Ki-67 and Aurora B expression in oral squamous cell carcinoma (OSCC) (22) . Notably, OSCC cases with nuclear Survivin and Aurora B expression exhibited marked malignant behavior. However, in this study, nuclear Survivin was not associated with Aurora B and pathological factors in colorectal carcinoma. The frequency of Survivin expression was extremely high in colorectal carcinomas compared with OSCC cases, thus nuclear Survivin may have varying roles in epithelial cancer and adenocarcinoma.
In this study, we found that the overexpression of nuclear Aurora B and cytoplasmic Survivin was significantly correlated with lymph node metastasis. Moreover, both nuclear Aurora B and cytoplasmic Survivin cases showed far poorer prognosis in colorectal carcinomas. Thus, nuclear Aurora B and cytoplasmic Survivin may be strong markers for the prediction of the malignancy of colorectal carcinomas.
In conclusion, our present findings showed that nuclear Aurora B and cytoplasmic Survivin expression are involved in lymph node metastasis, and both nuclear Aurora B and cytoplasmic Survivin are strongly associated with lymph node metastasis in colorectal cancer.
Therefore, we suggest that nuclear Aurora B and cytoplasmic Survivin are useful diagnostic markers and therapeutic targets in colorectal carcinoma.
